Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06988943

Early Intervention Strategies for Lung Cancer

Low-dose CT (LDCT)can detect and treat lung cancer earlier and more quickly, while expanded screening coverage helps reduce the incidence and mortality of respiratory diseases such as lung cancer. This study aims to conduct a single-arm cluster randomized trial of digitally enabled LDCT in Guangzhou to assess its intervention effectiveness and cost-effectiveness.

Recruiting

Interested in participating?

Request Info

Key information

Age range

40 year–74 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Cardiothoracic Surgery, the First Affiliated Hospital of Guangzhou Medical College

Guangzhou, Guangdong, 510120, China

Location status: Recruiting

Location contact

Jianxing He, MD

CONTACT

[email protected]

+86-20-83337792

About this study

This study uses a single-arm design to assign community health service centers in two districts of Guangzhou (Liwan and Baiyun) to the intervention group. A historical self-comparison design is employed. The intervention measures utilize a digital empowerment model for lung cancer screening, which includes the following components: ① Digital health platform: Each street and community health center manages resident information through the Lung Health mini-program; ② AI-based full-lung model reading system: Using artificial intelligence technology to assist in interpreting CT images; ③ Low-dose CT screening: Low-dose CT screening is conducted at primary healthcare institutions, and patients with detected lung nodules are referred to hospitals for further examination. The sampling method used is Probability Proportional to Size (PPS), with an expected sample size of 16000. Participants will complete the "Lung Cancer Health Questionnaire" to collect individual-level confounding factors. Screening data will be collected through the "Fei'anxin" mini-program, and diagnostic data will be provided by designated hospitals and the First Affiliated Hospital of Guangzhou Medical University. The primary outcome of the study is the proportion of early-stage lung cancer in the screening population, defined as the number of early-stage lung cancer cases divided by the total number of people screened. An economic evaluation of the lung cancer CT screening will also be conducted.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

1.Community Health Service Centers (Cluster Level)

  • Inclusion Criteria The community health service center must be located within one of the 11 districts of Guangzhou.

The center must manage a population of over 10,000 elderly individuals. The center should be equipped with at least one CT machine and have qualified medical personnel, such as radiologists, radiologic technicians, and nursing staff.

  • Exclusion Criteria Community health centers currently participating in other public health projects or studies that may affect screening results.

Community health service centers where researchers cannot collect data or conduct follow-up.

  • Screening Subjects (Individual Level)
  • Inclusion Criteria Aged 40-75 years. Residing in the community participating in the study for a long time. No known history of lung cancer and has not undergone lung cancer screening in the past three months.

Able to understand and willing to sign the informed consent form, and able to participate in long-term follow-up.

  • Exclusion Criteria Individuals diagnosed with lung cancer. Individuals with severe other health issues that make them unsuitable for CT imaging.

Individuals unable to understand the study protocol or who cannot provide informed consent due to cognitive impairments.

Individuals participating in other clinical trials that may affect the results of this study.

Individuals unable to undergo follow-up.

Treatment and study plan

Low-dose CT screening

Device

Low-dose CT screening is conducted at primary healthcare institutions, and patients with detected lung nodules are referred to hospitals for further examination

AI full-lung model interpretation system

Device

Using artificial intelligence technology to assist in the interpretation of CT images

Digital Health Platform

Device

Community health centers and streets in Guangzhou use a program called "Fei Anxin" to manage residents' information in a unified way

Primary outcomes

  1. The early diagnosis rate of lung cancer

    Time frame: Within 1 year after the intervention is implemented

Secondary outcomes

  1. The number of participants in lung cancer screening

    Time frame: Within 1 year after the intervention is implemented

  2. Number of individuals with positive screening results

    Time frame: Within one year after the intervention is implemented

  3. 3-month follow-up rate.

    Time frame: Within three months after the intervention is implemented

  4. One-year follow-up rate

    Time frame: Within 1 year after the intervention is implemented

  5. Diagnosis rate

    Time frame: Within 1 year after the intervention is implemented

  6. False positive rate for nodules

    Time frame: Within 1 year after the intervention is implemented

  7. Positive predictive value for nodules

    Time frame: Within 1 year after the intervention is implemented

  8. Average time to read CT images

    Time frame: Within 1 year after the intervention is implemented

  9. CT screening complications

    Time frame: Within 1 year after the intervention is implemented

  10. Complications of diagnostic tests

    Time frame: Within 1 year after the intervention is implemented

Study contacts

Contact information is provided by the study sponsor or research team.

Jianxing He, MD

CONTACT

[email protected]

86-20-83337792

Sponsors and collaborators

Lead sponsor

The First Affiliated Hospital of Guangzhou Medical University

Other

Registry information

Official study title

Construction and Evaluation of a Hospital-Community Health Collaboration Model Empowered by Digital Technology for Lung Cancer Screening

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
May 25, 2025
Registry last updated
May 30, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.